Screener
Monopar Therapeutics MNPR Invested capital
Discontinued — last reported Q1 '26
Invested capital at other companies
Other financials
Where this comes from
Calculated from Monopar Therapeutics’s reported figures.
The source filing: Monopar Therapeutics’s 10-Q, filed May 14, 2026. Open the filing →
- Filed
- May 14, 2026, 2:00 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001437749-26-016982
FAQ
- What is Monopar Therapeutics's invested capital?
- Monopar Therapeutics (MNPR) reported invested capital of $83.08M in Q1 2026.
- How has Monopar Therapeutics's invested capital changed year-over-year?
- Monopar Therapeutics's invested capital increased by 498.1% year-over-year, from $13.89M to $83.08M.
- What is the long-term trend for Monopar Therapeutics's invested capital?
- Over 2 years (2022 to 2025), Monopar Therapeutics's invested capital has grown at a 523.6% compound annual growth rate (CAGR), from $1.96M to $76.24M.
- What does invested capital mean?
- Total debt plus shareholders' equity minus cash, at the quarter end. The capital actually put to work in the operating business — the denominator of return on invested capital (ROIC).
Ask your AI about Monopar Therapeutics's invested capital.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude